Milestone Pharmaceuticals's market cap is currently $109.86M. The company's EPS TTM is $-0.897; its P/E ratio is ―; Milestone Pharmaceuticals is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is $-0.16. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 1.00M	$ 5.00M	$ 15.00M	$ 0.00	$ 0.00
Gross Profit	$ 1.00M	$ 4.52M	$ 15.00M	$ -376.00K	$ -236.00K
Operating Income	$ -61.10M	$ -59.64M	$ -43.07M	$ -50.71M	$ -57.88M
EBITDA	$ -56.84M	$ -58.36M	$ -42.98M	$ -50.71M	$ -57.88M
Net Income	$ -59.69M	$ -57.13M	$ -42.63M	$ -49.97M	$ -55.23M
Balance Sheet
Cash & Short-Term Investments	$ 66.00M	$ 64.58M	$ 114.14M	$ 142.31M	$ 119.82M
Total Assets	$ 75.23M	$ 74.48M	$ 119.85M	$ 149.97M	$ 123.43M
Total Debt	$ 51.77M	$ 2.49M	$ 698.00K	$ 941.00K	$ 514.00K
Net Debt	$ 38.02M	$ -5.14M	$ -113.44M	$ -71.37M	$ -119.30M
Total Liabilities	$ 58.45M	$ 8.13M	$ 7.25M	$ 6.86M	$ 8.51M
Stockholders' Equity	$ 16.77M	$ 66.35M	$ 112.60M	$ 143.12M	$ 114.92M
Cash Flow
Free Cash Flow	$ -46.54M	$ -52.74M	$ -33.22M	$ -50.73M	$ -51.56M
Operating Cash Flow	$ -46.42M	$ -52.47M	$ -33.22M	$ -50.73M	$ -51.15M
Investing Cash Flow	$ 4.76M	$ -57.12M	$ 70.00M	$ -70.00M	$ -384.00K
Financing Cash Flow	$ 47.79M	$ 3.09M	$ 5.05M	$ 73.22M	$ 85.41M

Currency in USD

Milestone Pharmaceuticals Earnings and Revenue History

Income Statement >

Milestone Pharmaceuticals Debt to Assets

Balance Sheet >

Milestone Pharmaceuticals Cash Flow

Cash Flow >

Milestone Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing